id: NEW:low_threshold_sud_bridge_clinic_access_to_sud_medication_treatment_rate_oud
name: Low-Threshold SUD Bridge Clinic Access â†’ SUD Medication Treatment Rate (OUD)
from_node:
  node_id: NEW:low_threshold_sud_bridge_clinic_access
  node_name: Low-Threshold SUD Bridge Clinic Access
to_node:
  node_id: sud_medication_treatment_rate_oud
  node_name: SUD Medication Treatment Rate (OUD)
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Bridge clinics provide same-day access to medications for SUD including buprenorphine'
- 'Step 2: Removal of prior authorization and waiting period barriers enables immediate medication initiation'
- 'Step 3: Transition to community-based providers maintains medication continuity'
- 'Step 4: 68% of follow-up participants continued taking SUD medications, with 46% on buprenorphine'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Sarah K Casey et al. 2024. "Linkage to Care Outcomes Following Treatment in A Low-Threshold
    Substance Use Disorder Bridge Clinic." https://doi.org/10.1177/29767342241261609
  supporting_citations:
  - Additional citations require full-text access - abstract references medication-assisted treatment
    literature
  - Additional citations require full-text access - abstract references buprenorphine access literature
  - Additional citations require full-text access - abstract references treatment retention literature
  doi: 10.1177/29767342241261609
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Bridge clinic model facilitates medication-assisted treatment for SUD, with 68% of patients
  continuing medications at follow-up and 46% specifically on buprenorphine, demonstrating that low-barrier
  access to medications improves ongoing pharmacotherapy utilization.
quantitative_effects:
  effect_size:
    value: 68.0
    type: percentage_change
  sample_size: 63
structural_competency:
  equity_implications: The traditional barriers to medication-assisted treatment (X-waiver requirements,
    prior authorizations, limited prescribers) create structural inequities in accessing evidence-based
    OUD treatment. This model demonstrates that structural interventions removing these barriers improve
    medication treatment rates.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.776770'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
